Ballmer mulls buying Adobe

The dark satanic rumour mill has manufactured a hell on earth yarn which claims that Microsoft is thinking of buying Adobe.

The word on the street is that “boss of the year” and serial chair chucker Steve “sounds of silence” Ballmer has been wining and dining Adobe CEO Shantanu Narayen.

You can take the information with a grain of salt because the rumour comes from the Apple press office, or New York Times as it is sometimes called. According to the Times, Ballmer and Adobe are so terrified by the might of Steve Jobs that they are considering uniting to deal with him.

The Times said a meeting, which lasted “more than an hour” dealt with Apple and its control of the mobile phone market and how the two companies could team up in the battle against Cupertino.

On the table was the acquisition of Adobe by Microsoft.

Adobe and Microsoft are rivals with competing software. This is particularly true since 2007 when Microsoft began promoting Silverlight, its software plug-in which is a rival to Adobe Flash.

But the New York Times claimed that the pair were scared of the block that Steve Jobs had placed on Adobe’s Flash software for its hand-held devices. Strangely, although the block has been well publicised by the US press who drink Apple’s Kool Aid, it is widely seen as being a total farce. Apple’s lack of Flash has been a sales opportunity for Android.

Buy out talks between Microsoft and Adobe happened a few years ago. But Microsoft backed out fearing that the DoJ would get it on anti-trust grounds. But things have changed with Google and Apple becoming more important players. These days such a deal would not be stopped.

While it does make sense for Microsoft to buy Adobe, it is less likely to be because of Apple. Adobe sits on some very good technology which works well with Redmond’s Office software. Its web systems are more popular than Silverlight will ever be. It would be good for Adobe software because Redmond would spend a large amount of resources making the technology more secure, better and more likely to survive in the future.